Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests that MiRNA-331-3p, by decreasing the expression of its target gene, may enhance cardiac function. Thus, pharmacological formulations encompassing “MiRNA-331-3p or its activators“ may be used to treat Cardiac Ischemic injury.
Courtesy: When you cite drop us a line at firstname.lastname@example.org
Undisclosed information: How MiRNA-331-3p protects against Cardiac Ischemic injury.